UROHEALTH SYSTEMS' $70.1 MIL. ACQUISITION OF IMAGYN WOULD ALLOW EXPANDED MARKETING OF IMAGYN GYNECOLOGY PRODUCTS; DEAL CAPS TWO-YEAR BUYING SPREE
This article was originally published in The Gray Sheet
Executive SummaryUrohealth's planned $70.1 mil. acquisition of Imagyn Medical would expand the market presence of Imagyn's gynecological device products by putting them in the hands of Urohealth's direct sales force.
You may also be interested in...
The North American trade organization’s new website offers consumers a gateway into the world of fragrance. Providing a “deep dive” into 50 fragrance ingredients, as well as overviews of perfumery, key regulations, and industry safety practices and sustainability efforts, the site extends FCA’s work to engage and inform consumers at a time of growing interest in manufactured scents.
The European Commission has set aside, for now, concerns expressed by member states regarding the scope of medicines subjected to additional monitoring requirements.